320 related articles for article (PubMed ID: 2306061)
1. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
[TBL] [Abstract][Full Text] [Related]
2. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
Osteyee JL; Banner W
Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of intravenous ranitidine after bolus and continuous infusion in patients with healed duodenal ulcers.
Sanders SW; Buchi KN; Moore JG; Bishop AL
Clin Pharmacol Ther; 1989 Nov; 46(5):545-51. PubMed ID: 2582711
[TBL] [Abstract][Full Text] [Related]
4. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
[TBL] [Abstract][Full Text] [Related]
5. Effect of 6-hourly intermittent intravenous boluses of oxmetidine and ranitidine on gastric acidity and serum prolactin.
Fölsch UR; Wichmann GC; Torossian A
Eur J Clin Pharmacol; 1987; 33(3):267-71. PubMed ID: 2891536
[TBL] [Abstract][Full Text] [Related]
6. Control of gastric pH with ranitidine in critically ill patients. Comparison of two intravenous regimens.
Santucci L; Fiorucci S; Pelli MA; Calderazzo A; Biasini E; Calderazzo PL; Morelli A
Dig Dis Sci; 1991 May; 36(5):583-7. PubMed ID: 2022159
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous infusion of ranitidine on intragastric acidity in fasting subjects: comparison with bolus or Gastrojet (pH-stat-adjusted) infusion.
Thomson AB; Kirdeikis P; Simon K; Zuk L; Pinchbeck B; Wasarab-Rolland D; Kersey K
Aliment Pharmacol Ther; 1993 Dec; 7(6):649-53. PubMed ID: 8161672
[TBL] [Abstract][Full Text] [Related]
8. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
[TBL] [Abstract][Full Text] [Related]
9. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
Bachmann K; Sullivan TJ; Jauregui L
J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
Kiilerich S; Rannem T; Elsborg L
Digestion; 1995; 56(1):25-30. PubMed ID: 7895928
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
Mathôt RA; Geus WP
Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two ranitidine intravenous infusion regimens in critically ill patients.
Marchant J; Summers K; McIsaac RL; Wood JR
Aliment Pharmacol Ther; 1988 Feb; 2(1):55-63. PubMed ID: 2979234
[TBL] [Abstract][Full Text] [Related]
14. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
[TBL] [Abstract][Full Text] [Related]
15. Intragastric pH and pharmacokinetics of intravenous ranitidine during sinusoidal and constant-rate infusions.
Sanders SW; Bishop AL; Moore JG
Chronobiol Int; 1991; 8(4):267-76. PubMed ID: 1797416
[TBL] [Abstract][Full Text] [Related]
16. Intravenous cimetidine or two regimens of ranitidine to reduce fasting gastric acidity.
Peterson WL; Richardson CT
Ann Intern Med; 1986 Apr; 104(4):505-7. PubMed ID: 3954278
[TBL] [Abstract][Full Text] [Related]
17. Single dose treatment with H2 receptor antagonists: is bedtime administration too late?
Merki H; Witzel L; Harre K; Scheurle E; Neumann J; Röhmel J
Gut; 1987 Apr; 28(4):451-4. PubMed ID: 3583073
[TBL] [Abstract][Full Text] [Related]
18. Assessment of 24-hour gastric pH measurements in trauma patients receiving intravenous famotidine by intermittent bolus versus continuous infusion administration.
Jones LA; Gonzalez ER; Reines HD; Venitz J
Ann Pharmacother; 1994; 28(7-8):841-4. PubMed ID: 7949496
[TBL] [Abstract][Full Text] [Related]
19. Day-night and individual differences in response to constant-rate ranitidine infusion.
White C; Smolensky MH; Sanders SW; Buchi KN; Moore JG
Chronobiol Int; 1991 Feb; 8(1):56-66. PubMed ID: 1814603
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
Baghaie AA; Mojtahedzadeh M; Levine RL; Fromm RE; Guntupalli KK; Opekun AR
Crit Care Med; 1995 Apr; 23(4):687-91. PubMed ID: 7712759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
